Day: March 15, 2022

Inozyme Pharma Reports Full Year 2021 Financial Results and Provides Business Highlights

Written by Customer Service on March 15, 2022. Posted in Earnings Releases And Operating Results.

– Phase 1/2 trial of INZ-701 in adult patients with ENPP1 Deficiency underway – – Expect to enroll first patient in Phase 1/2 trial of INZ-701 for ABCC6 Deficiency in the second quarter of 2022 – – Preliminary safety and biomarker data from Phase 1/2 trials in ENPP1 Deficiency and ABCC6 Deficiency on track for the first half of 2022 – BOSTON, March 15, 2022 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today reported financial results for the full year ended December 31, 2021, and provided recent business highlights. “2021 was a transformational year for Inozyme, as we continued to progress our INZ-701 program and graduated to a clinical-stage company. We initiated our first clinical trial...

Reviva Pharmaceuticals Holdings, Inc. Reports Full Year 2021 Financial Results and Recent Business Highlights

Written by Customer Service on March 15, 2022. Posted in Earnings Releases And Operating Results.

– Topline data for pivotal Phase 3 trial evaluating brilaroxazine for the treatment of schizophrenia anticipated in mid-2023 – $29.7 Million in Cash as of December 31, 2021 – CUPERTINO, Calif., March 15, 2022 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today reported financial results for the full year ended December 31, 2021 and summarized recent business highlights. “2021 was a year of significant progress that capped off with initiation of our pivotal Phase 3 and long-term safety trials in January evaluating brilaroxazine in schizophrenia. We are highly...

Northview Fund Announces 2021 Financial Results

Written by Customer Service on March 15, 2022. Posted in Earnings Releases And Operating Results.

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, March 15, 2022 (GLOBE NEWSWIRE) — Northview Fund (“Northview” or the “Fund”, formerly known as Northview Canadian High Yield Residential Fund) (NHF.UN – TSX), today announced financial results for the three months and year ended December 31, 2021. The comparative information included for the period ended December 31, 2020 reflects results for the period from November 2, 2020, the date on which Northview began operations, to December 31, 2020. While comparative information is presented on a quarterly and annual basis, the operating periods in the period ended December 31, 2020 and the year ended December 31, 2021 cover different time frames and, as such, are not comparable. All amounts in this news release are in thousands...

CarLotz Announces Fourth Quarter and Fiscal 2021 Financial Results

Written by Customer Service on March 15, 2022. Posted in Earnings Releases And Operating Results.

Fourth Quarter Revenue Grew 124% versus Last Year to $83.1 million Fourth Quarter Retail Unit Sales Grew 49% versus Last Year to 2,695Fourth Quarter F&I Revenue Grew 139% versus Last Year RICHMOND, Va., March 15, 2022 (GLOBE NEWSWIRE) — CarLotz, Inc. (“CarLotz” or the “Company”), a leading consignment-to-retail used vehicle marketplace, today announced financial results for the fourth quarter and fiscal year ended December 31, 2021. Fourth Quarter 2021 Financial ResultsNet revenue increased 124% to $83.1 million from $37.0 million in the same period in 2020 Retail unit sales increased 49% to 2,695 compared to 1,815 in the same period in 2020 Finance & insurance revenue increased 139% to $2.9 million in the same period in 2020 Gross profit was $2.4 million compared to $2.5 million in the same period last year Retail...

Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021

Written by Customer Service on March 15, 2022. Posted in Earnings Releases And Operating Results.

Research & Development Highlights:In January of 2022, announced positive topline results from Phase 2 EMPATHY clinical trial of ensovibep for the treatment of non-hospitalized COVID-19 patients, resulting in the option exercise of the program by Novartis triggering the receipt of CHF 150 million in January 2022 Continued to confirm ensovibep’s pan-variant activity in in vitro studies demonstrating maintained high potency against all known SARS-CoV-2 variants of concern, including Omicron, Delta and Lambda Received FDA Fast Track designation for ensovibep for the treatment of COVID-19 Dosed more than 560 patients across clinical studies for ensovibep Announced collaboration with Novartis to develop DARPin-conjugated radioligand therapies for oncology Initiated enrollment in Phase 1 study of MP0317 targeting FAP and CD40 Nominated...

NewLake Capital Partners Declares First Quarter 2022 Common Stock Dividend

Written by Customer Service on March 15, 2022. Posted in Dividend Reports And Estimates.

NEW CANAAN, Conn., March 15, 2022 (GLOBE NEWSWIRE) — NewLake Capital Partners, Inc. (OTCQX: NLCP) (“The Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced that its board of directors has declared a first quarter 2022 cash dividend of $0.33 per share of common stock. The dividend is equivalent to an annualized dividend of $1.32 per common share, and is the Company’s fourth consecutive quarterly dividend increase. The dividends are payable on April 14, 2022 to stockholders of record at the close of business on March 31, 2022. About NewLake Capital Partners, Inc. NewLake Capital Partners, Inc. is an internally-managed real estate investment trust that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions and third-party...

RioCan Real Estate Investment Trust Announces March 2022 Distribution

Written by Customer Service on March 15, 2022. Posted in Dividend Reports And Estimates.

TORONTO, March 15, 2022 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan”) (TSX: REI.UN) today announced a distribution of 8.5 cents per unit for the month of March. The distribution will be payable on April 7, 2022 to unitholders of record as at March 31, 2022. About RioCanRioCan is one of Canada’s largest real estate investment trusts. RioCan owns, manages and develops retail-focused, increasingly mixed-use properties located in prime, high-density transit-oriented areas where Canadians want to shop, live and work. As at December 31, 2021, our portfolio is comprised of 207 properties with an aggregate net leasable area of approximately 36.4 million square feet (at RioCan’s interest) including office, residential rental and 13 development properties. To learn more about us, please visit www.riocan.com. CONTACT:...

Peyto Exploration & Development Corp. Confirms Monthly Dividend For April 14, 2022

Written by Customer Service on March 15, 2022. Posted in Dividend Reports And Estimates.

CALGARY, Alberta, March 15, 2022 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to March 2022 of $0.05 per common share is to be paid on April 14, 2022, for shareholders of record on March 31, 2022. The ex-dividend date for the March dividend is March 30, 2022. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes the President’s monthly report, which discusses various topics chosen by the President and includes estimates of monthly capital expenditures and production. For further...

Northview Fund Announces March Distribution

Written by Customer Service on March 15, 2022. Posted in Dividend Reports And Estimates.

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, March 15, 2022 (GLOBE NEWSWIRE) — Northview Fund (the “Fund”) today announced its March 2022 cash distribution amounts on its outstanding Class A Units, Class C Units and Class F Units Class (collectively, the “Units”), payable on April 19, 2022 to holders of Units of record at March 31, 2022. The distribution amounts will be as follows:C$0.10476 per Class A Unit, representing approximately C$1.26 per Unit on an annualized basis; C$0.11056 per Class C Unit, representing approximately C$1.33 per Unit on an annualized basis; C$0.10807 per Class F Unit, representing approximately C$1.30 per Unit on an annualized basis;About Northview Fund The Fund is a “closed-end fund” established pursuant to a declaration of trust under...

CAPREIT Announces March 2022 Distribution

Written by Customer Service on March 15, 2022. Posted in Dividend Reports And Estimates.

TORONTO, March 15, 2022 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX – CAR.UN) announced today its March 2022 monthly distribution in the amount of $0.12083 per Unit (or $1.45 on an annualized basis). The March distribution will be payable on April 18, 2022 to Unitholders of record on March 31, 2022. To encourage participation and reward our loyal Unitholders, investors registered in our Distribution Reinvestment Plan will continue to receive an additional amount equal to 5% of their distributions paid in the form of additional Units. CAPREIT is Canada’s largest publicly-traded provider of quality rental housing. CAPREIT currently owns or has interests in approximately 67,000 residential apartment suites, townhomes and manufactured housing community sites well-located across Canada...

Day: March 15, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice